IHE vs. IAK
Compare and contrast key facts about iShares U.S. Pharmaceuticals ETF (IHE) and iShares U.S. Insurance ETF (IAK).
IHE and IAK are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. IAK is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Insurance Index. It was launched on May 5, 2006. Both IHE and IAK are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IHE or IAK.
Correlation
The correlation between IHE and IAK is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
IHE vs. IAK - Performance Comparison
Key characteristics
IHE:
0.88
IAK:
1.82
IHE:
1.31
IAK:
2.45
IHE:
1.16
IAK:
1.33
IHE:
1.13
IAK:
2.76
IHE:
2.74
IAK:
10.50
IHE:
3.91%
IAK:
2.60%
IHE:
12.17%
IAK:
15.03%
IHE:
-38.20%
IAK:
-77.38%
IHE:
-9.53%
IAK:
-9.90%
Returns By Period
In the year-to-date period, IHE achieves a 7.58% return, which is significantly lower than IAK's 25.52% return. Over the past 10 years, IHE has underperformed IAK with an annualized return of 3.94%, while IAK has yielded a comparatively higher 11.66% annualized return.
IHE
7.58%
-1.52%
-0.62%
9.27%
5.83%
3.94%
IAK
25.52%
-6.76%
10.01%
26.17%
13.84%
11.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IHE vs. IAK - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is lower than IAK's 0.43% expense ratio.
Risk-Adjusted Performance
IHE vs. IAK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and iShares U.S. Insurance ETF (IAK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IHE vs. IAK - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.62%, less than IAK's 1.88% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.41% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% | 1.06% |
IAK iShares U.S. Insurance ETF | 1.53% | 1.44% | 1.69% | 2.26% | 2.07% | 1.84% | 2.33% | 1.62% | 1.68% | 1.62% | 1.57% | 1.14% |
Drawdowns
IHE vs. IAK - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, smaller than the maximum IAK drawdown of -77.38%. Use the drawdown chart below to compare losses from any high point for IHE and IAK. For additional features, visit the drawdowns tool.
Volatility
IHE vs. IAK - Volatility Comparison
The current volatility for iShares U.S. Pharmaceuticals ETF (IHE) is 3.11%, while iShares U.S. Insurance ETF (IAK) has a volatility of 5.10%. This indicates that IHE experiences smaller price fluctuations and is considered to be less risky than IAK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.